Established in 2019, Recircle SA, distributes its product, Mucopolysaccharide sodium in the global market to internationally renowned pharmaceutical companies.

Recircle SA has created a proprietary process for dealing with impurities and composition separation and activity release technologies in the production of Mucopolysaccharide sodium.

Recircle SA has established a comprehensive quality management system in line with South Africa, cGMP standards and regulations. Recircle SA is approved by the South Africa regulatory authorities and is also one of the primary participants in the revision of the South Africa pharmacopeia standards.